Diagnostic test
BCR/ABL QUALITATIVE (MBCR-CML) - (Outlab)
About test
What does BCR/ABL QUALITATIVE (MBCR-CML) - (Outlab) measure?
This qualitative molecular test detects the BCR::ABL gene fusion associated with chronic myeloid leukemia (CML), particularly the major breakpoint cluster region (MBCR) transcripts. It may be used to help evaluate suspected CML, support diagnosis alongside other clinical and laboratory findings, or assess the presence of this genetic marker during follow-up. Results should be interpreted by a healthcare professional in the context of symptoms, blood counts, and other tests.
This overview is educational. Use the recorded preparation, sample and lab-partner details below for collection guidance, and confirm any missing information before collection.
Choose a laboratory
Compare eligible lab partners
Prices, report times and availability are shown from the catalog records for each eligible partner.
Thyrocare
- Sample for analysis
- Confirm with the collection team
- Report time
- To be confirmed
Preparation and specimen requirements can vary by test and laboratory. Follow the instructions shown for your selected partner and any advice from your healthcare professional.